ATr Inhibitor in Combination With Olaparib in Gynaecological Cancers With ARId1A Loss or no Loss

Condition:   Gynaecological Cancers Interventions:   Drug: AZD6738;   Drug: Olaparib Sponsors:   Institute of Cancer Research, United Kingdom;   Cancer Research UK;   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials